TCN2 expression in monocytes was correlated with markers of disease progression, including SLEDAI-2K and complement C3/C4, suggesting that TCN2 could serve as a potential biomarker for SLE progression. The gene discussed is C4A; the disease is systemic lupus erythematosus.